牙科设备

Search documents
现代牙科回购10.00万股股票,共耗资约43.62万港元,本年累计回购592.70万股
Jin Rong Jie· 2025-07-08 11:17
7月8日,现代牙科回购10.00万股股票,每股回购均价4.36港元,共耗资约43.62万港元,本年累计回购 592.70万股,占总股本0.63%。 现代牙科是一家在港股上市的公司,专注于牙科领域。它在牙科产品的研发、生产和销售方面有着广泛 的业务布局。现代牙科的产品涵盖了多个方面,包括义齿、牙科设备及相关牙科材料等。在牙科行业 中,现代牙科凭借其技术研发能力、生产工艺以及广泛的销售网络占据一定的市场地位。其生产的义齿 产品能够满足不同客户的需求,无论是从质量还是从美观度等方面都具有一定的竞争力。公司在市场上 的表现也受到多种因素的影响,如牙科行业整体的发展趋势、技术创新、市场竞争格局以及全球经济环 境等。在全球范围内,随着人们对口腔健康的重视程度不断提高,牙科市场有着广阔的发展前景,现代 牙科也在这样的市场环境下不断发展并通过回购股票等方式来优化公司的资本结构和市场形象。 本文源自:金融界 作者:港股君 现代牙科近期回购情况 回购日期回购均价回购股数回购金额本年累计回购股数2025-07-084.36210.00万43.62万592.70万2025-07- 074.31610.00万43.16万582.70万 ...
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics
ZACKS· 2025-05-05 18:00
Core Insights - Henry Schein reported $3.17 billion in revenue for Q1 2025, a slight year-over-year decline of 0.1% [1] - The EPS for the quarter was $1.15, up from $1.10 a year ago, indicating a positive trend in earnings [1] - The revenue fell short of the Zacks Consensus Estimate of $3.23 billion by 1.84%, while the EPS exceeded the consensus estimate of $1.11 by 3.60% [1] Revenue Performance - Geographic Revenue from International Dental Equipment was $197 million, below the average estimate of $209.20 million [4] - U.S. Distribution Revenue for Dental Equipment was $187 million, significantly lower than the estimated $232.79 million, reflecting a 25.4% decline year-over-year [4] - International Dental Merchandise revenue was $594 million, also below the estimate of $608.26 million [4] - U.S. Distribution Medical revenue was $1.03 billion, slightly above the estimate of $1.01 billion, showing a year-over-year increase of 1.6% [4] - International Dental revenue was $798 million, under the estimate of $824.47 million, with a year-over-year decline of 1.6% [4] - U.S. Distribution Dental Merchandise revenue was $591 million, exceeding the estimate of $569.68 million [4] - Global Specialty Products net sales were $367 million, slightly above the average estimate of $364.59 million [4] Stock Performance - Henry Schein's shares returned -0.3% over the past month, contrasting with the Zacks S&P 500 composite's +0.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]